Bin Yuan
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
-
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 6
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Bogang Wu (6 shared papers)Yanfen Hu (7 shared papers)Tyler J. Curiel (5 shared papers)Andleeb Zameer (1 shared paper)Gaddam Narsa Goud (1 shared paper)Ruitian Liu (1 shared paper)Philip Schulz (1 shared paper)Yuri L. Lyubchenko (1 shared paper)
- Journals
- International Journal of Clinical and Experimental Pathology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Nature Communications (1 paper)Signal Transduction and Targeted Therapy (1 paper)OncoImmunology (1 paper)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Bin Yuan
18 papers receiving 415 citations
Peers
Comparison fields: 5 of 73
- Oncology 125
- Immunology 94
- Physiology 90
- Neurology 26
- Biological Psychiatry 7
Countries citing papers authored by Bin Yuan
This map shows the geographic impact of Bin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Yuan more than expected).
Fields of papers citing papers by Bin Yuan
This network shows the impact of papers produced by Bin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Yuan. The network helps show where Bin Yuan may publish in the future.
Co-authors
The 25 scholars most cited alongside Bin Yuan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 97 | |
| 2 | 2018 | 76 | |
| 3 | 2021 | 51 | |
| 4 | 2021 | 36 | |
| 5 | 2018 | 24 | |
| 6 | 2018 | 21 | |
| 7 | 2020 | 18 | |
| 8 | 2019 | 16 | |
| 9 | Association of the ARL15 rs6450176 SNP and serum lipid levels in the Jing and Han populations. | 2015 | 15 |
| 10 | 2023 | 12 | |
| 11 | Suppressor of cytokine signaling 3 A+930-->G (rs4969168) polymorphism is associated with apolipoprotein A1 and low-density lipoprotein cholesterol. | 2015 | 10 |
| 12 | 2022 | 9 | |
| 13 | 2018 | 9 | |
| 14 | Sex-specific association of the SPTY2D1 rs7934205 polymorphism and serum lipid levels. | 2015 | 9 |
| 15 | 2024 | 4 | |
| 16 | 2021 | 4 | |
| 17 | Association of the SPT2 chromatin protein domain containing 1 gene rs17579600 polymorphism and serum lipid traits. | 2015 | 3 |
| 18 | Association of RBM5 rs2013208 SNP with serum lipid levels in two Chinese ethnic groups. | 2017 | 2 |
| 19 | 2021 | 0 |
About Bin Yuan
Bin Yuan is a scholar working on Molecular Biology, Oncology, Immunology, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 19 papers that have together received 416 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers), T-cell and B-cell Immunology (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), Adipose Tissue and Metabolism (2 papers), Macrophage Migration Inhibitory Factor (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Oncology (125 citations), Immunology (94 citations), Physiology (90 citations), Neurology (26 citations) and Biological Psychiatry (7 citations). Bin Yuan has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Bogang Wu, Yanfen Hu, Tyler J. Curiel, Andleeb Zameer, Gaddam Narsa Goud, Ruitian Liu, Philip Schulz, Yuri L. Lyubchenko, Huai-Chin Chiang and Michael R. Sierks. Their work appears in journals such as International Journal of Clinical and Experimental Pathology, Journal for ImmunoTherapy of Cancer, Nature Communications, Signal Transduction and Targeted Therapy and OncoImmunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.